dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Fucà, Giovanni |
dc.contributor.author | Cohen, Romain |
dc.contributor.author | Shitara, Kohei |
dc.contributor.author | Elez Fernandez, Mª Elena |
dc.contributor.author | Diez Garcia, Marc |
dc.contributor.author | Fakih, Marwan |
dc.contributor.author | Lonardi, Sara |
dc.date.accessioned | 2022-08-10T11:39:02Z |
dc.date.available | 2022-08-10T11:39:02Z |
dc.date.issued | 2022-02 |
dc.identifier.citation | Fucà G, Cohen R, Lonardi S, Shitara K, Elez ME, Fakih M, et al. Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers. J Immunother Cancer. 2022 Feb;10(2):e004001. |
dc.identifier.issn | 2051-1426 |
dc.identifier.uri | https://hdl.handle.net/11351/7983 |
dc.description | Neoplasias gastrointestinales; Inmunoterapia; Biomarcadores tumorales |
dc.language.iso | eng |
dc.publisher | BMJ |
dc.relation.ispartofseries | Journal for ImmunoTherapy of Cancer;10(12) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Còlon - Càncer - Tractament |
dc.subject | Recte - Càncer - Tractament |
dc.subject | Ascites |
dc.subject.mesh | Antineoplastic Agents |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Ascites |
dc.title | Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/jitc-2021-004001 |
dc.subject.decs | antineoplásicos |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | ascitis |
dc.relation.publishversion | http://dx.doi.org/10.1136/jitc-2021-004001 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Fucà G] Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Cohen R] Sorbonne Université, Department of Medical Oncology, Hôpital Saint-Antoine, APHP and INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France. [Lonardi S] Medical Oncology 3 Medical Oncology 1, Istituto Oncologico Veneto IOV-IRCSS, Padua, Italy. [Shitara K] Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. [Elez ME, Díez García M] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Fakih M] Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA |
dc.identifier.pmid | 35110358 |
dc.identifier.wos | 000758164800002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |